NASDAQ:IART is probably undervalued for the fundamentals it is displaying.

Uncover the potential of INTEGRA LIFESCIENCES HOLDING (NASDAQ:IART) as our stock screener's choice for an undervalued stock. NASDAQ:IART maintains a strong financial position and offers an appealing valuation. We'll delve into the specifics below.

Evaluating Valuation: NASDAQ:IART

An integral part of ChartMill's stock analysis is the Valuation Rating, which spans from 0 to 10. This rating evaluates diverse valuation factors, including price to earnings and cash flows, while considering the stock's profitability and growth. NASDAQ:IART has received a 8 out of 10:

• With a Price/Earnings ratio of 10.89, the valuation of IART can be described as very reasonable.
• 96.43% of the companies in the same industry are more expensive than IART, based on the Price/Earnings ratio.
• IART is valuated cheaply when we compare the Price/Earnings ratio to 26.17, which is the current average of the S&P500 Index.
• A Price/Forward Earnings ratio of 10.26 indicates a reasonable valuation of IART.
• Based on the Price/Forward Earnings ratio, IART is valued cheaper than 96.94% of the companies in the same industry.
• The average S&P500 Price/Forward Earnings ratio is at 22.53. IART is valued rather cheaply when compared to this.
• IART's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. IART is cheaper than 93.88% of the companies in the same industry.
• Compared to the rest of the industry, the Price/Free Cash Flow ratio of IART indicates a rather cheap valuation: IART is cheaper than 84.69% of the companies listed in the same industry.
• IART has a very decent profitability rating, which may justify a higher PE ratio.

Analyzing Profitability Metrics

ChartMill utilizes a Profitability Rating to assess stocks, scoring them on a scale of 0 to 10. This rating takes into account a variety of profitability ratios and margins, both in absolute terms and in comparison to industry peers. NASDAQ:IART has earned a 7 out of 10:

• With a decent Return On Assets value of 1.79%, IART is doing good in the industry, outperforming 73.47% of the companies in the same industry.
• IART has a Return On Equity of 4.27%. This is in the better half of the industry: IART outperforms 75.00% of its industry peers.
• IART has a better Return On Invested Capital (6.57%) than 83.67% of its industry peers.
• With a decent Profit Margin value of 4.39%, IART is doing good in the industry, outperforming 75.51% of the companies in the same industry.
• IART has a better Operating Margin (17.63%) than 91.33% of its industry peers.
• IART's Operating Margin has improved in the last couple of years.
• IART's Gross Margin of 63.09% is fine compared to the rest of the industry. IART outperforms 63.78% of its industry peers.

Analyzing Health Metrics

ChartMill assigns a Health Rating to every stock. This score ranges from 0 to 10 and evaluates the different health aspects like liquidity and solvency, both absolutely, but also relative to the industry peers. NASDAQ:IART scores a 5 out of 10:

• IART has a Altman-Z score of 1.96. This is in the better half of the industry: IART outperforms 61.22% of its industry peers.
• Looking at the Debt to FCF ratio, with a value of 20.52, IART is in the better half of the industry, outperforming 72.45% of the companies in the same industry.
• IART has a Current Ratio of 3.45. This indicates that IART is financially healthy and has no problem in meeting its short term obligations.
• IART has a Quick Ratio of 2.18. This indicates that IART is financially healthy and has no problem in meeting its short term obligations.

Growth Analysis for NASDAQ:IART

A key component of ChartMill's stock assessment is the Growth Rating, which spans from 0 to 10. This rating evaluates diverse growth factors, such as EPS and revenue growth, considering both past performance and future projections. NASDAQ:IART has received a 4 out of 10:

• The Earnings Per Share is expected to grow by 13.76% on average over the next years. This is quite good.
• The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
• When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

Every day, new Decent Value stocks can be found on ChartMill in our Decent Value screener.

Our latest full fundamental report of IART contains the most current fundamental analsysis.

Keep in mind

Important Note: The content of this article is not intended as trading advice. It is essential to perform your own analysis and exercise caution when making trading decisions. The article presents observations created by automated analysis but does not guarantee any trading or investment outcomes. Always trade responsibly and make independent judgments.